SCHEMBL4855165

SCHEMBL4855165

COc1ccc(C(=O)CCCCN(CCc2ccccc2)C(=O)O)cc1NS(C)(=O)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
KMT2A Q03164 2/20 0.46
ALDH1A1 P00352 2/20 0.46
MEN1 O00255 1/20 0.46
POLB P06746 2/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
PDE4D Q08499 2/20 0.45
NR3C1 P04150 2/20 0.44
LTB4R Q15722 1/20 0.43
ADRB3 P13945 1/20 0.42
PDE4A P27815 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4C Q08493 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LPAR1 Q92633 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4858869 0.99 SMN1; SMN2 (0.45) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL4855322 0.91 ALDH1A1 (0.44) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL4862142 0.90 ALDH1A1 (0.44) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL4855030 0.89 KMT2A (0.42) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL4851734 0.89 KMT2A (0.41) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL4860212 0.88 MEN1 (0.42) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL4857352 0.88 MEN1 (0.42) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL13987492 0.84 HDAC1 (0.51) SMN1; SMN2KMT2AALDH1A1MEN1POLB
Hydrochloric Acid SCHEMBL4862348 0.83 HDAC1 (0.50) SMN1; SMN2KMT2AALDH1A1MEN1POLB
SCHEMBL13987498 0.83 HDAC1 (0.50) SMN1; SMN2KMT2AALDH1A1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed
US-7138533-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-21 US disclosed
US-7132547-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-07 US disclosed
US-20060211675-A1 Preventives/remedies for urinary disturbance ISHIHARA YUJI 2006-09-21 US disclosed
US-20060063769-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-03-23 US disclosed
US-20050197362-A1 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-08 US disclosed
EP-1466625-A1 PREVENTIVES/REMEDIES FOR URINARY DISTURBANCE Takeda Chemical Industries, Ltd. (JP) 2004-10-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060063769-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 SMN1; SMN2 1472/4885KMT2A 2316/4885ALDH1A1 118/4885
US-20050197362-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, CHRM1 SMN1; SMN2 1472/4885KMT2A 2316/4885ALDH1A1 118/4885
US-20060211675-A1 Preventives/remedies for urinary disturbance ACHE, BPHL, ACE SMN1; SMN2 1418/4885KMT2A 1894/4885ALDH1A1 212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.